Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis

被引:56
作者
Gotoh, Saki [1 ]
Negishi, Masahiko [1 ]
机构
[1] NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
关键词
COA REDUCTASE INHIBITORS; CROSS-TALK; GLUCOSE; MOUSE; CAR;
D O I
10.1038/srep14076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Statin therapy is known to increase blood glucose levels in humans. Statins utilize pregnane X receptor (PXR) and serum/glucocorticoid regulated kinase 2 (SGK2) to activate phosphoenolpyruvate carboxykinase 1 (PEPCK1) and glucose-6-phosphatase (G6Pase) genes, thereby increasing glucose production in human liver cells. Here, the novel statin/PXR/SGK2-mediated signaling pathway has now been characterized for hepatic gluconeogenesis. Statin-activated PXR scaffolds the protein phosphatase 2C (PP2C) and SGK2 to stimulate PP2C to dephosphorylate SGK2 at threonine 193. Non-phosphorylated SGK2 co-activates PXR-mediated trans-activation of promoters of gluconeogenic genes in human liver cells, thereby enhancing gluconeogenesis. This gluconeogenic statin-PXR-SGK2 signal is not present in mice, in which statin treatment suppresses hepatic gluconeogenesis. These findings provide the basis for statin-associated side effects such as an increased risk for Type 2 diabetes.
引用
收藏
页数:10
相关论文
共 18 条
[1]   Sanguinarine as a Potent and Specific Inhibitor of Protein Phosphatase 2C in Vitro and Induces Apoptosis via Phosphorylation of p38 in HL60 Cells [J].
Aburai, Nobuhiro ;
Yoshida, Mami ;
Ohnishi, Motoko ;
Kimura, Ken-ichi .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (03) :548-552
[2]   Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α -: Functional implications in hepatic cholesterol and glucose metabolism [J].
Bhalla, S ;
Ozalp, C ;
Fang, SS ;
Xiang, LJ ;
Kemper, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :45139-45147
[3]   Statin treatment and new-onset diabetes: A review of proposed mechanisms [J].
Brault, Marilyne ;
Ray, Jessica ;
Gomez, Yessica-Haydee ;
Mantzoros, Christos S. ;
Daskalopoulou, Stella S. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (06) :735-745
[4]  
Carter A. A., 2013, BMJ-BRIT MED J, V347, pf2616, DOI [10.1136/bmjf2610, DOI 10.1136/BMJF2610]
[5]   Serum- and Glucocorticoid-Regulated Kinase 2 Determines Drug-Activated Pregnane X Receptor to Induce Gluconeogenesis in Human Liver Cells [J].
Gotoh, Saki ;
Negishi, Masahiko .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (01) :131-140
[6]   The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes [J].
Howe, Katharine ;
Sanat, Faizah ;
Thumser, Alfred E. ;
Coleman, Tanya ;
Plant, Nick .
XENOBIOTICA, 2011, 41 (07) :519-529
[7]   An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway [J].
Kliewer, SA ;
Moore, JT ;
Wade, L ;
Staudinger, JL ;
Watson, MA ;
Jones, SA ;
McKee, DD ;
Oliver, BB ;
Willson, TM ;
Zetterström, RH ;
Perlmann, T ;
Lehmann, JM .
CELL, 1998, 92 (01) :73-82
[8]   Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor [J].
Kobayashi, K ;
Yamanaka, Y ;
Iwazaki, N ;
Nakajo, I ;
Hosokawa, M ;
Negishi, M ;
Chiba, K .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) :924-929
[9]   Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase [J].
Kobayashi, T ;
Deak, M ;
Morrice, N ;
Cohen, P .
BIOCHEMICAL JOURNAL, 1999, 344 :189-197
[10]   Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes [J].
Kodama, S ;
Koike, C ;
Negishi, M ;
Yamamoto, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (18) :7931-7940